Antje Schaefer & Channing J. Der. (2022) RHOA takes the RHOad less traveled to cancer. Trends in Cancer 8:8, pages 655-669.
Crossref
Christian Johnson, Deborah L. Burkhart & Kevin M. Haigis. (2022)
Classification of
KRAS
-Activating Mutations and the Implications for Therapeutic Intervention
. Cancer Discovery 12:4, pages 913-923.
Crossref
Christina Mayerhofer, Charlotte M. Niemeyer & Christian Flotho. (2021) Current Treatment of Juvenile Myelomonocytic Leukemia. Journal of Clinical Medicine 10:14, pages 3084.
Crossref
Ishani Banik, Phil F. Cheng, Christopher M. Dooley, Jana Travnickova, Munise Merteroglu, Reinhard Dummer, Elizabeth E. Patton, Elisabeth M. Busch‐Nentwich & Mitchell P. Levesque. (2020)
NRAS
Q61K
melanoma tumor formation is reduced by p38‐MAPK14 activation in zebrafish models and NRAS‐mutated human melanoma cells
. Pigment Cell & Melanoma Research 34:2, pages 150-162.
Crossref
Atsuko Ogino, Jihyun Choi, Mika Lin, Margaret K. Wilkens, Antonio Calles, Man Xu, Anika E. Adeni, Emily S. Chambers, Marzia Capelletti, Mohit Butaney, Nathanael S. Gray, Prafulla C. Gokhale, Sangeetha Palakurthi, Paul Kirschmeier, Geoffrey R. Oxnard, Lynette M. Sholl & Pasi A. Jänne. (2020) Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations. Molecular Oncology 15:1, pages 27-42.
Crossref
Haisheng Zhang, Antje Schaefer, Yichen Wang, Richard G. Hodge, Devon R. Blake, J. Nathaniel Diehl, Alex G. Papageorge, Matthew D. Stachler, Jennifer Liao, Jin Zhou, Zhong Wu, Fahire G. Akarca, Leonie K. de Klerk, Sarah Derks, Mariaelena Pierobon, Katherine A. Hoadley, Timothy C. Wang, George Church, Kwok-Kin Wong, Emanuel F. Petricoin, Adrienne D. Cox, Douglas R. Lowy, Channing J. Der & Adam J. Bass. (2020)
Gain-of-Function
RHOA
Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer
. Cancer Discovery 10:2, pages 288-305.
Crossref
Nathaniel C. Noyes, Erica Walkinshaw & Ronald L. Davis. (2020)
Ras acts as a molecular switch between two forms of consolidated memory in
Drosophila
. Proceedings of the National Academy of Sciences 117:4, pages 2133-2139.
Crossref
G. Aaron Hobbs, Nicole M. Baker, Anne M. Miermont, Ryan D. Thurman, Mariaelena Pierobon, Timothy H. Tran, Andrew O. Anderson, Andrew M. Waters, J. Nathaniel Diehl, Bjoern Papke, Richard G. Hodge, Jennifer E. Klomp, Craig M. Goodwin, Jonathan M. DeLiberty, Junning Wang, Raymond W.S. Ng, Prson Gautam, Kirsten L. Bryant, Dominic Esposito, Sharon L. Campbell, Emanuel F. PetricoinIIIIII, Dhirendra K. Simanshu, Andrew J. Aguirre, Brian M. Wolpin, Krister Wennerberg, Udo Rudloff, Adrienne D. Cox & Channing J. Der. (2020) Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer. Cancer Discovery 10:1, pages 104-123.
Crossref
D. E. Demin, M. A. Afanasyeva, A. N. Uvarova, M. M. Prokofjeva, A. M. Gorbachova, A. S. Ustiugova, A. V. Klepikova, L. V. Putlyaeva, K. A. Tatosyan, P. V. Belousov & A. M. Schwartz. (2019) Constitutive Expression of NRAS with Q61R Driver Mutation Activates Processes of Epithelial–Mesenchymal Transition and Leads to Substantial Transcriptome Change of Nthy-ori 3–1 Thyroid Epithelial Cells. Biochemistry (Moscow) 84:4, pages 416-425.
Crossref
Joanna R. Kovalski, Aparna Bhaduri, Ashley M. Zehnder, Poornima H. Neela, Yonglu Che, Glenn G. Wozniak & Paul A. Khavari. (2019) The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. Molecular Cell 73:4, pages 830-844.e12.
Crossref
Allyson K. Roof, Tammy Trudeau & Arthur Gutierrez-Hartmann. (2018) Pituitary somatolactotropes evade an oncogenic response to Ras. Molecular and Cellular Endocrinology 476, pages 165-172.
Crossref
Zachary J. Messenger, Jonathan R. Hall, Dereje D. Jima, John S. House, Hann W. Tam, Debra A. Tokarz & Robert C. Smart. (2018) C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event. Cell Death & Disease 9:11.
Crossref
Hanna Shin, Rebecca E.W. Kaplan, Tam Duong, Razan Fakieh & David J. Reiner. (2018) Ral Signals through a MAP4 Kinase-p38 MAP Kinase Cascade in C. elegans Cell Fate Patterning. Cell Reports 24:10, pages 2669-2681.e5.
Crossref
Olivier Ganier, Dominik Schnerch, Philipp Oertle, Roderick YH Lim, Marija Plodinec & Erich A Nigg. (2018) Structural centrosome aberrations promote non‐cell‐autonomous invasiveness. The EMBO Journal 37:9.
Crossref
Yasuyuki Hosono, Yashar S. Niknafs, John R. Prensner, Matthew K. Iyer, Saravana M. Dhanasekaran, Rohit Mehra, Sethuramasundaram Pitchiaya, Jean Tien, June Escara-Wilke, Anton Poliakov, Shih-Chun Chu, Sahal Saleh, Keerthana Sankar, Fengyun Su, Shuling Guo, Yuanyuan Qiao, Susan M. Freier, Huynh-Hoa Bui, Xuhong Cao, Rohit Malik, Timothy M. Johnson, David G. Beer, Felix Y. Feng, Weibin Zhou & Arul M. Chinnaiyan. (2017) Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA. Cell 171:7, pages 1559-1572.e20.
Crossref
Bong Seok Kang, Yoon Jin Hwang & Zigang Dong. (2017) ERK1 Directly Interacts With JNK1 Leading to Regulation of JNK1/c-Jun Activity and Cell Transformation. Journal of Cellular Biochemistry 118:8, pages 2357-2370.
Crossref
Anastasios D Giannou, Antonia Marazioti, Nikolaos I Kanellakis, Ioanna Giopanou, Ioannis Lilis, Dimitra E Zazara, Giannoula Ntaliarda, Danai Kati, Vasileios Armenis, Georgia A Giotopoulou, Anthi C Krontira, Marina Lianou, Theodora Agalioti, Malamati Vreka, Maria Papageorgopoulou, Sotirios Fouzas, Dimitrios Kardamakis, Ioannis Psallidas, Magda Spella & Georgios T Stathopoulos. (2017)
NRAS
destines tumor cells to the lungs
. EMBO Molecular Medicine 9:5, pages 672-686.
Crossref
Guowei Yin, Samantha Kistler, Samuel D. George, Nora Kuhlmann, Leslie Garvey, Minh Huynh, Rachel K. Bagni, Michael Lammers, Channing J. Der & Sharon L. Campbell. (2017) A KRAS GTPase K104Q Mutant Retains Downstream Signaling by Offsetting Defects in Regulation. Journal of Biological Chemistry 292:11, pages 4446-4456.
Crossref
Hossein Nakhaeizadeh, Ehsan Amin, Saeideh Nakhaei-Rad, Radovan Dvorsky & Mohammad Reza Ahmadian. (2016) The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. PLOS ONE 11:12, pages e0167145.
Crossref
Pascale Tomasini, Preet Walia, Catherine Labbe, Kevin Jao & Natasha B. Leighl. (2016) Targeting the KRAS Pathway in Non-Small Cell Lung Cancer. The Oncologist 21:12, pages 1450-1460.
Crossref
Shaoyong Lu, Hyunbum Jang, Serena Muratcioglu, Attila Gursoy, Ozlem Keskin, Ruth Nussinov & Jian Zhang. (2016) Ras Conformational Ensembles, Allostery, and Signaling. Chemical Reviews 116:11, pages 6607-6665.
Crossref
Carla Ferrándiz-Pulido, Javier Hernández-Losa, Emili Masferrer, Ana Vivancos, Rosa Somoza, Roso Marés, Claudia Valverde, Carlos Salvador, Jose Placer, Juan Morote, Ramon M. Pujol, Santiago Ramon, y Cajal, Ines de Torres, Agusti Toll & Vicente García-Patos. (2015) Identification of somatic gene mutations in penile squamous cell carcinoma. Genes, Chromosomes and Cancer 54:10, pages 629-637.
Crossref
Nikitha K. Pallegar, D. Craig Ayre & Sherri L. Christian. (2015) Repression of CD24 surface protein expression by oncogenic Ras is relieved by inhibition of Raf but not MEK or PI3K. Frontiers in Cell and Developmental Biology 3.
Crossref
Dominic Leiser, Michaela Medová, Kei Mikami, Lluís Nisa, Deborah Stroka, Andree Blaukat, Friedhelm Bladt, Daniel M. Aebersold & Yitzhak Zimmer. (2015) KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET-expressing tumor cells. Molecular Oncology 9:7, pages 1434-1446.
Crossref
Arun M Unni, William W Lockwood, Kreshnik Zejnullahu, Shih-Queen Lee-Lin & Harold Varmus. (2015) Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma. eLife 4.
Crossref
Yao Tong, Lisa Y. Yung & Yung H. Wong. (2015) Metastasis suppressors Nm23H1 and Nm23H2 differentially regulate neoplastic transformation and tumorigenesis. Cancer Letters 361:2, pages 207-217.
Crossref
Murugabaskar Balan, Eduardo Mier y Teran, Ana Maria Waaga-Gasser, Martin Gasser, Toni K. Choueiri, Gordon Freeman & Soumitro Pal. (2015) Novel Roles of c-Met in the Survival of Renal Cancer Cells through the Regulation of HO-1 and PD-L1 Expression. Journal of Biological Chemistry 290:13, pages 8110-8120.
Crossref
Gregor Hoermann, Katharina Blatt, Georg Greiner, Eva Maria Putz, Angelika Berger, Harald Herrmann, Sabine Cerny‐Reiterer, Karoline V. Gleixner, Christoph Walz, Konrad Hoetzenecker, Leonhard Müllauer, Andreas Reiter, Karl Sotlar, Veronika Sexl, Peter Valent & Matthias Mayerhofer. (2014) CD52 is a molecular target in advanced systemic mastocytosis. The FASEB Journal 28:8, pages 3540-3551.
Crossref
T W Chew, X J Liu, L Liu, J M Spitsbergen, Z Gong & B C Low. (2013) Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models. Oncogene 33:21, pages 2717-2727.
Crossref
Hiromichi Ebi, Anthony C. Faber, Jeffrey A. Engelman & Seiji Yano. (2014)
Not just g
RAS
ping at flaws: Finding vulnerabilities to develop novel therapies for treating
KRAS
mutant cancers
. Cancer Science 105:5, pages 499-505.
Crossref
Joseph M. Catanzaro, Namratha Sheshadri, Ji-An Pan, Yu Sun, Chanjuan Shi, Jinyu Li, R. Scott Powers, Howard C. Crawford & Wei-Xing Zong. (2014) Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4. Nature Communications 5:1.
Crossref
Lindsey K. Boroughs, Marc A. Antonyak & Richard A. Cerione. (2014) A Novel Mechanism by Which Tissue Transglutaminase Activates Signaling Events That Promote Cell Survival. Journal of Biological Chemistry 289:14, pages 10115-10125.
Crossref
Ryan W Serra, Minggang Fang, Sung Mi Park, Lloyd Hutchinson & Michael R Green. (2014) A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype. eLife 3.
Crossref
Guillaume Vandal, Benjamin Geiling & David Dankort. (2014) Ras Effector Mutant Expression Suggest a Negative Regulator Inhibits Lung Tumor Formation. PLoS ONE 9:1, pages e84745.
Crossref
Tikvah K. Hayes & Channing J. Der. 2014. Ras Superfamily Small G Proteins: Biology and Mechanisms 1. Ras Superfamily Small G Proteins: Biology and Mechanisms 1
135
156
.
Daniel J. Gough, Lisa Koetz & David E. Levy. (2013) The MEK-ERK Pathway Is Necessary for Serine Phosphorylation of Mitochondrial STAT3 and Ras-Mediated Transformation. PLoS ONE 8:11, pages e83395.
Crossref
Yingchun Wang, Yao Tong, Prudence H. Tso & Yung H. Wong. (2013) Regulator of G protein signaling 19 suppresses Ras-induced neoplastic transformation and tumorigenesis. Cancer Letters 339:1, pages 33-41.
Crossref
Shashikiran Donthamsetty, Vishakha S. Bhave, Wendy M. Mars, William C. Bowen, Anne Orr, Meagan M. Haynes, Chuanyue Wu & George K. Michalopoulos. (2013) Role of PINCH and Its Partner Tumor Suppressor Rsu-1 in Regulating Liver Size and Tumorigenesis. PLoS ONE 8:9, pages e74625.
Crossref
David F. Kashatus. (2013) Ral GTPases in tumorigenesis: Emerging from the shadows. Experimental Cell Research 319:15, pages 2337-2342.
Crossref
Xing-gang Mao, Marianne Hütt-Cabezas, Brent A. Orr, Melanie Weingart, Isabella Taylor, Anand K.D. Rajan, Yazmin Odia, Ulf Kahlert, Jarek Maciaczyk, Guido Nikkhah, Charles G. Eberhart & Eric H. Raabe. (2013) LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program. Oncotarget 4:7, pages 1050-1064.
Crossref
Yuanxiang Wang, Christine E. Kaiser, Brendan Frett & Hong-yu Li. (2013) Targeting Mutant KRAS for Anticancer Therapeutics: A Review of Novel Small Molecule Modulators. Journal of Medicinal Chemistry 56:13, pages 5219-5230.
Crossref
Yufang Wang, Sérgia Velho, Efsevia Vakiani, Shouyong Peng, Adam J. Bass, Gerald C. Chu, Jessica Gierut, James M. Bugni, Channing J. Der, Mark Philips, David B. Solit & Kevin M. Haigis. (2013) Mutant N-RAS Protects Colorectal Cancer Cells from Stress-Induced Apoptosis and Contributes to Cancer Development and Progression. Cancer Discovery 3:3, pages 294-307.
Crossref
Wiyada Kwanhian, Dido Lenze, Julia Alles, Natalie Motsch, Stephanie Barth, Celina Döll, Jochen Imig, Michael Hummel, Marianne Tinguely, Pankaj Trivedi, Viraphong Lulitanond, Gunter Meister, Christoph Renner & Friedrich A. Grässer. (2012)
Micro
RNA
‐142 is mutated in about 20% of diffuse large
B
‐cell lymphoma
. Cancer Medicine 1:2, pages 141-155.
Crossref
Minja Laulajainen, Maria Melikova, Taru Muranen, Olli Carpén & Mikaela Grönholm. (2012) Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity. Journal of Cellular and Molecular Medicine 16:9, pages 2161-2175.
Crossref
Monica Musteanu, Leander Blaas, Rainer Zenz, Jasmin Svinka, Thomas Hoffmann, Beatrice Grabner, Daniel Schramek, Hans-Peter Kantner, Mathias Müller, Thomas Kolbe, Thomas Rülicke, Richard Moriggl, Lukas Kenner, Dagmar Stoiber, Josef Martin Penninger, Helmut Popper, Emilio Casanova & Robert Eferl. (2012) A mouse model to identify cooperating signaling pathways in cancer. Nature Methods 9:9, pages 897-900.
Crossref
Ariel F. Castro, Tania Campos, Justin T. Babcock, Marisol E. Armijo, Alfonso Martínez-Conde, Roxana Pincheira & Lawrence A. Quilliam. (2012) M-Ras induces Ral and JNK activation to regulate MEK/ERK-independent gene expression in MCF-7 breast cancer cells. Journal of Cellular Biochemistry 113:4, pages 1253-1264.
Crossref
David Horst, Justina Chen, Teppei Morikawa, Shuji Ogino, Thomas Kirchner & Ramesh A. Shivdasani. (2012) Differential WNT Activity in Colorectal Cancer Confers Limited Tumorigenic Potential and Is Regulated by MAPK Signaling. Cancer Research 72:6, pages 1547-1556.
Crossref
D P Mathiasen, C Egebjerg, S H Andersen, B Rafn, P Puustinen, A Khanna, M Daugaard, E Valo, S Tuomela, T Bøttzauw, C F Nielsen, B M Willumsen, S Hautaniemi, R Lahesmaa, J Westermarck, M Jäättelä & T Kallunki. (2011) Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation. Oncogene 31:3, pages 390-401.
Crossref
Hong-Qiang Wang, Xin-Ping Xie & Chun-Hou Zheng. 2012. Bio-Inspired Computing and Applications. Bio-Inspired Computing and Applications
610
617
.
Pallavi Banerjee, Aninda Basu, Dipak Datta, Martin Gasser, Ana Maria Waaga-Gasser & Soumitro Pal. (2011) The Heme Oxygenase-1 Protein Is Overexpressed in Human Renal Cancer Cells following Activation of the Ras-Raf-ERK Pathway and Mediates Anti-Apoptotic Signal. Journal of Biological Chemistry 286:38, pages 33580-33590.
Crossref
Aninda Basu, Pallavi Banerjee, Alan G. Contreras, Evelyn Flynn & Soumitro Pal. (2011) Calcineurin Inhibitor-Induced and Ras-Mediated Overexpression of VEGF in Renal Cancer Cells Involves mTOR through the Regulation of PRAS40. PLoS ONE 6:8, pages e23919.
Crossref
M C Hollander, C R Maier, E A Hobbs, A R Ashmore, R I Linnoila & P A Dennis. (2011) Akt1 deletion prevents lung tumorigenesis by mutant K-ras. Oncogene 30:15, pages 1812-1821.
Crossref
Eva Chung & Motonari Kondo. (2010) Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development. Immunologic Research 49:1-3, pages 248-268.
Crossref
Yeon-Gu Kim, Young Kue Han, Jee Yon Kim, Eun Gyo Lee, Hong Weon Lee & Gyun Min Lee. (2011) Effect of constitutively active ras overexpression on cell growth in recombinant chinese hamster ovary cells. Biotechnology Progress 27:2, pages 577-580.
Crossref
Karl C. Bruckman, Frank Schönleben, Wanglong Qiu, Victoria L. Woo & Gloria H. Su. (2010) Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 110:5, pages 632-637.
Crossref
P A Zipfel, D C Brady, D F Kashatus, B D Ancrile, D S Tyler & C M Counter. (2010) Ral activation promotes melanomagenesis. Oncogene 29:34, pages 4859-4864.
Crossref
Shayne Cox GadArianna Loregian & Giorgio Palù. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Gretchen A. Repasky, Adrienne D. Cox, Ariella B. Hanker, Natalia Mitin & Channing J. Der. 2010. Handbook of Cell Signaling. Handbook of Cell Signaling
1753
1762
.
Anne Laure Ramon & Claude Malvy. 2010. Macromolecular Anticancer Therapeutics. Macromolecular Anticancer Therapeutics
539
568
.
Dipak Datta, Alan G. Contreras, Aninda Basu, Olivier Dormond, Evelyn Flynn, David M. Briscoe & Soumitro Pal. (2009) Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells. Cancer Research 69:23, pages 8902-8909.
Crossref
Gloria Fuentes & Alfonso Valencia. (2009) Ras classical effectors: new tales from in silico complexes. Trends in Biochemical Sciences 34:11, pages 533-539.
Crossref
Junhye Kwon, Susann Stephan, Ananya Mukhopadhyay, Michael H. Muders, Shamit K. Dutta, Julie S. Lau & Debabrata Mukhopadhyay. (2009) Insulin Receptor Substrate-2 Mediated Insulin-like Growth Factor-I Receptor Overexpression in Pancreatic Adenocarcinoma through Protein Kinase Cδ. Cancer Research 69:4, pages 1350-1357.
Crossref
Nathan T. Ihle, Robert LemosJr.Jr., Peter Wipf, Adly Yacoub, Clint Mitchell, Doris Siwak, Gordon B. Mills, Paul Dent, D. Lynn Kirkpatrick & Garth Powis. (2009) Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance. Cancer Research 69:1, pages 143-150.
Crossref
C Leikam, A Hufnagel, M Schartl & S Meierjohann. (2008) Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence. Oncogene 27:56, pages 7070-7082.
Crossref
P Taghavi, E Verhoeven, J J L Jacobs, J P Lambooij, C Stortelers, E Tanger, W H Moolenaar & M van Lohuizen. (2008) In vitro genetic screen identifies a cooperative role for LPA signaling and c-Myc in cell transformation. Oncogene 27:54, pages 6806-6816.
Crossref
Elisa Ferro, David Magrini, Paolo Guazzi, Thomas H. FischerSara Pistolesi, Rebecca Pogni, Gilbert C. WhiteIIIILorenza Trabalzini. (2008) G-protein binding features and regulation of the RalGDS family member, RGL2. Biochemical Journal 415:1, pages 145-154.
Crossref
Nicole Fehrenbacher, Lone Bastholm, Thomas Kirkegaard-Sørensen, Bo Rafn, Trine Bøttzauw, Christina Nielsen, Ekkehard Weber, Senji Shirasawa, Tuula Kallunki & Marja Jäättelä. (2008) Sensitization to the Lysosomal Cell Death Pathway by Oncogene-Induced Down-regulation of Lysosome-Associated Membrane Proteins 1 and 2. Cancer Research 68:16, pages 6623-6633.
Crossref
Jessica Plati, Octavian Bucur & Roya Khosravi‐Far. (2008) Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities. Journal of Cellular Biochemistry 104:4, pages 1124-1149.
Crossref
Tadhg P. BegleyEmily J. Chenette & Channing J. Der. 2007. Wiley Encyclopedia of Chemical Biology. Wiley Encyclopedia of Chemical Biology.
Patiyan Andersson, Aleksandra Kolaric, Torgny Windahl, Peter Kirrander, Peter Söderkvist & Mats G. Karlsson. (2008)
PIK3CA, HRAS
and
KRAS
Gene Mutations in Human Penile Cancer
. Journal of Urology 179:5, pages 2030-2034.
Crossref
Thomas Willemsen, Urs B. Hagemann, Eva M. Jouaux, Sabine C. Stebel, Jody M. Mason, Kristian M. Müller & Katja M. Arndt. 2008. Molecular Biomethods Handbook. Molecular Biomethods Handbook
587
629
.
Adam Shutes, Cercina Onesto, Virginie Picard, Bertrand Leblond, Fabien Schweighoffer & Channing J. Der. (2007) Specificity and Mechanism of Action of EHT 1864, a Novel Small Molecule Inhibitor of Rac Family Small GTPases. Journal of Biological Chemistry 282:49, pages 35666-35678.
Crossref
Josh A Noser, Amber A Mael, Ryuta Sakuma, Seiga Ohmine, Paola Marcato, Patrick WK Lee & Yasuhiro Ikeda. (2007) The RAS/Raf1/MEK/ERK Signaling Pathway Facilitates VSV-mediated Oncolysis: Implication for the Defective Interferon Response in Cancer Cells. Molecular Therapy 15:8, pages 1531-1536.
Crossref
Aparna Kaul, Jean H. Overmeyer & William A. Maltese. (2007) Activated Ras induces cytoplasmic vacuolation and non-apoptotic death in glioblastoma cells via novel effector pathways. Cellular Signalling 19:5, pages 1034-1043.
Crossref
Suzanne Schubbert, Kevin Shannon & Gideon Bollag. (2007) Hyperactive Ras in developmental disorders and cancer. Nature Reviews Cancer 7:4, pages 295-308.
Crossref
Travis W. Young, Fang C. Mei, Daniel G. Rosen, Gong Yang, Nan Li, Jinsong Liu & Xiaodong Cheng. (2007) Up-regulation of Tumor Susceptibility Gene 101 Protein in Ovarian Carcinomas Revealed by Proteomics Analyses. Molecular & Cellular Proteomics 6:2, pages 294-304.
Crossref
Christina Nielsen, Jacob Thastrup, Trine Bøttzauw, Marja Jäättelä & Tuula Kallunki. (2007) c-Jun NH2-Terminal Kinase 2 Is Required for Ras Transformation Independently of Activator Protein 1. Cancer Research 67:1, pages 178-185.
Crossref
Dipak Datta, Jesse A. Flaxenburg, Sreenivas Laxmanan, Christopher Geehan, Martin Grimm, Ana Maria Waaga-Gasser, David M. Briscoe & Soumitro Pal. (2006) Ras-induced Modulation of CXCL10 and Its Receptor Splice Variant CXCR3-B in MDA-MB-435 and MCF-7 Cells: Relevance for the Development of Human Breast Cancer. Cancer Research 66:19, pages 9509-9518.
Crossref
Soon-Jeong Jeong, Su-Gwan Kim, Jiyun Yoo, Mi-Young Han, Joo-Cheol Park, Heung-Joong Kim, Seong Soo Kang, Baik-Dong Choi & Moon-Jin Jeong. (2006) Increased Association of Dynamin II with Myosin II in Ras Transformed NIH3T3 Cells. Acta Biochimica et Biophysica Sinica 38:8, pages 556-562.
Crossref
Paul M. Campbell, Anurag Singh, Falina J. Williams, Karen Frantz, Aylin S. Ülfü, Grant G. Kelley & Channing J. Der. 2006. Regulators and Effectors of Small GTPases: Ras Family. Regulators and Effectors of Small GTPases: Ras Family
195
217
.
Jean De Gunzburg. 2006. RAS Family GTPases. RAS Family GTPases
295
339
.
Kian-Huat Lim & Christopher M. Counter. 2006. RAS Family GTPases. RAS Family GTPases
257
272
.
Maya Shmulevitz, Paola Marcato & Patrick W K Lee. (2005) Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer. Oncogene 24:52, pages 7720-7728.
Crossref
Patricia J. Keller, Christyn M. Gable, Michele R. Wing & Adrienne D. Cox. (2005) Rac3-Mediated Transformation Requires Multiple Effector Pathways. Cancer Research 65:21, pages 9883-9890.
Crossref
Ron Wisdom, Lyanne Huynh, Datsun Hsia & Sungeun Kim. (2005) RAS and TGF-β exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation. Oncogene 24:47, pages 7043-7054.
Crossref
Alexander P. DucruetAndreas VogtPeter Wipf & John S. Lazo. (2005) DUAL SPECIFICITY PROTEIN PHOSPHATASES: Therapeutic Targets for Cancer and Alzheimer's Disease. Annual Review of Pharmacology and Toxicology 45:1, pages 725-750.
Crossref
Bu Young Choi, Hong Seok Choi, Kwangseok Ko, Yong-Yeon Cho, Feng Zhu, Bong Seok Kang, Svetlana P Ermakova, Wei-Ya Ma, Ann M Bode & Zigang Dong. (2005) The tumor suppressor p16INK4a prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activity. Nature Structural & Molecular Biology 12:8, pages 699-707.
Crossref
Daniel R Rhodes, Scott A Tomlins, Sooryanarayana Varambally, Vasudeva Mahavisno, Terrence Barrette, Shanker Kalyana-Sundaram, Debashis Ghosh, Akhilesh Pandey & Arul M Chinnaiyan. (2005) Probabilistic model of the human protein-protein interaction network. Nature Biotechnology 23:8, pages 951-959.
Crossref
Carmen A. Argmann, Jane Y. Edwards, Cynthia G. Sawyez, Caroline H. O'Neil, Robert A. Hegele, J. Geoffrey Pickering & Murray W. Huff. (2005) Regulation of Macrophage Cholesterol Efflux through Hydroxymethylglutaryl-CoA Reductase Inhibition. Journal of Biological Chemistry 280:23, pages 22212-22221.
Crossref
Alam Nur-E-Kamal, Ailing Zhang, Susan M. Keenan, Xin I. Wang, Jabed Seraj, Takaya Satoh, Sally Meiners & William J. Welsh. (2005) Requirement of Activated Cdc42-Associated Kinase for Survival of v-Ras-Transformed Mammalian Cells. Molecular Cancer Research 3:5, pages 297-305.
Crossref
Julien Mazières, Vanessa Tillement, Cuider Allal, Carine Clanet, Lisbeth Bobin, Zhi Chen, Said M. Sebti, Gilles Favre & Anne Pradines. (2005) Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells. Experimental Cell Research 304:2, pages 354-364.
Crossref
Elena Tchevkina, Larisa Agapova, Natalya Dyakova, Anna Martinjuk, Andrei Komelkov & Alexander Tatosyan. (2004) The small G-protein RalA stimulates metastasis of transformed cells. Oncogene 24:3, pages 329-335.
Crossref
Roberto Diaz, Jeffrey Lue, Jeremy Mathews, Andrew Yoon, Daniel Ahn, Antonio Garcia-España, Peter Leonardi, Marcelo P. Vargas & Angel Pellicer. (2005) Inhibition of Ras oncogenic activity by Ras protooncogenes. International Journal of Cancer 113:2, pages 241-248.
Crossref
Klaudia Giehl. (2005) Oncogenic Ras in tumour progression and metastasis. Biological Chemistry 386:3.
Crossref
Todd R. Palmby, Karon Abe, Antoine E. Karnoub & Channing J. Der. (2004) Vav Transformation Requires Activation of Multiple GTPases and Regulation of Gene Expression. Molecular Cancer Research 2:12, pages 702-711.
Crossref
Tai-Guang Jin, Alexei Kurakin, Nordine Benhaga, Karon Abe, Mehrdad Mohseni, Ferry Sandra, Keli Song, Brian K. Kay & Roya Khosravi-Far. (2004) Fas-associated Protein with Death Domain (FADD)-independent Recruitment of c-FLIPL to Death Receptor 5. Journal of Biological Chemistry 279:53, pages 55594-55601.
Crossref
Gretchen A. Repasky, Emily J. Chenette & Channing J. Der. (2004) Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?. Trends in Cell Biology 14:11, pages 639-647.
Crossref
John Collette, Aylin S. Ulku, Channing J. Der, Anta'Sha Jones & Ann H. Erickson. (2004) Enhanced cathepsin L expression is mediated by different Ras effector pathways in fibroblasts and epithelial cells. International Journal of Cancer 112:2, pages 190-199.
Crossref
Ali Bounacer, Alex McGregor, Julia Skinner, Jane Bond, Zara Poghosyan & David Wynford-Thomas. (2004) Mutant ras-induced proliferation of human thyroid epithelial cells requires three effector pathways. Oncogene 23:47, pages 7839-7845.
Crossref
A.-M. Conway, A.B. James, E.M. O'Kane, S. Rakhit & B.J. Morris. (2004) Regulation of myosin light chain phosphorylation by RhoB in neuronal cells. Experimental Cell Research 300:1, pages 35-42.
Crossref
Jing ZhangHarvey F. Lodish. (2004) Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors. Blood 104:6, pages 1679-1687.
Crossref
Galit Elad-Sfadia, Roni Haklai, Eyal Balan & Yoel Kloog. (2004) Galectin-3 Augments K-Ras Activation and Triggers a Ras Signal That Attenuates ERK but Not Phosphoinositide 3-Kinase Activity. Journal of Biological Chemistry 279:33, pages 34922-34930.
Crossref
Kian-Huat Lim & Christopher M. Counter. (2004) Leveling the Playing Field. Molecular Cell 15:4, pages 491-492.
Crossref
Chang Feng Chen, Philippe Goyette & David Lohnes. (2004) RARγ acts as a tumor suppressor in mouse keratinocytes. Oncogene 23:31, pages 5350-5359.
Crossref
Jesse A. Flaxenburg, Michael Melter, Peter H. Lapchak, David M. Briscoe & Soumitro Pal. (2004) The CD40-Induced Signaling Pathway in Endothelial Cells Resulting in the Overexpression of Vascular Endothelial Growth Factor Involves Ras and Phosphatidylinositol 3-Kinase. The Journal of Immunology 172:12, pages 7503-7509.
Crossref
Alexandre Nesterov, Malti Nikrad, Thomas Johnson & Andrew S. Kraft. (2004) Oncogenic Ras Sensitizes Normal Human Cells to Tumor Necrosis Factor-α-Related Apoptosis-Inducing Ligand-Induced Apoptosis. Cancer Research 64:11, pages 3922-3927.
Crossref
Barak Rotblat, Hagit Niv, Sabine André, Herbert Kaltner, Hans-Joachim Gabius & Yoel Kloog. (2004) Galectin-1(L11A) Predicted from a Computed Galectin-1 Farnesyl-Binding Pocket Selectively Inhibits Ras-GTP. Cancer Research 64:9, pages 3112-3118.
Crossref
Natalia Y. Mitin, Melissa B. Ramocki, Alfred J. Zullo, Channing J. Der, Stephen F. Konieczny & Elizabeth J. Taparowsky. (2004) Identification and Characterization of Rain, a Novel Ras-interacting Protein with a Unique Subcellular Localization. Journal of Biological Chemistry 279:21, pages 22353-22361.
Crossref
Jianguo Du, Bo Jiang, Robert J. Coffey & John Barnard. (2004) Raf and RhoA Cooperate to Transform Intestinal Epithelial Cells and Induce Growth Resistance to Transforming Growth Factor β. Molecular Cancer Research 2:4, pages 233-241.
Crossref
Paul M Campbell & Channing J Der. (2004) Oncogenic Ras and its role in tumor cell invasion and metastasis. Seminars in Cancer Biology 14:2, pages 105-114.
Crossref
Antoine E. Karnoub, Marc Symons, Sharon L. Campbell & Channing J. Der. (2004) Molecular Basis for Rho GTPase Signaling Specificity. Breast Cancer Research and Treatment 84:1, pages 61-71.
Crossref
Iris T. Chan, Jeffery L. Kutok, Ifor R. Williams, Sarah Cohen, Lauren Kelly, Hirokazu Shigematsu, Leisa Johnson, Koichi Akashi, David A. Tuveson, Tyler Jacks & D. Gary Gilliland. (2004) Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. Journal of Clinical Investigation 113:4, pages 528-538.
Crossref
Iris T. Chan, Jeffery L. Kutok, Ifor R. Williams, Sarah Cohen, Lauren Kelly, Hirokazu Shigematsu, Leisa Johnson, Koichi Akashi, David A. Tuveson, Tyler Jacks & D. Gary Gilliland. (2004) Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. Journal of Clinical Investigation 113:4, pages 528-538.
Crossref
Matthias Neid, Kaustubh Datta, Susann Stephan, Ila Khanna, Soumitro Pal, Leslie Shaw, Morris White & Debabrata Mukhopadhyay. (2004) Role of Insulin Receptor Substrates and Protein Kinase C-ζ in Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression in Pancreatic Cancer Cells. Journal of Biological Chemistry 279:6, pages 3941-3948.
Crossref
Aylin S. Ülkü & Channing J. Der. 2004. Signal Transduction in Cancer. Signal Transduction in Cancer
189
208
.
Marcos Rivas & Pilar Santisteban. (2003) TSH-activated signaling pathways in thyroid tumorigenesis. Molecular and Cellular Endocrinology 213:1, pages 31-45.
Crossref
GARY OXFORD & DAN THEODORESCU. (2003) Review Article: The Role of Ras Superfamily Proteins in Bladder Cancer Progression. Journal of Urology 170:5, pages 1987-1993.
Crossref
Vyacheslav A. Adarichev, Rita Vaiskunaite, Jiaxin Niu, Irina V. Balyasnikova & Tatyana A. Voyno-Yasenetskaya. (2003)
Gα
13
-mediated transformation and apoptosis are permissively dependent on basal ERK activity
. American Journal of Physiology-Cell Physiology 285:4, pages C922-C934.
Crossref
Andrew H. Fischer, Panya Taysavang & Sissy M. Jhiang. (2003) Nuclear Envelope Irregularity Is Induced by RET/PTC During Interphase. The American Journal of Pathology 163:3, pages 1091-1100.
Crossref
John T. Fassett, Diane Tobolt, Christopher J. Nelsen, Jeffrey H. Albrecht & Linda K. Hansen. (2003) The Role of Collagen Structure in Mitogen Stimulation of ERK, Cyclin D1 Expression, and G1-S Progression in Rat Hepatocytes. Journal of Biological Chemistry 278:34, pages 31691-31700.
Crossref
F Chang, L S Steelman, J T Lee, J G Shelton, P M Navolanic, W L Blalock, R A Franklin & J A McCubrey. (2003) Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17:7, pages 1263-1293.
Crossref
Bo Jiang, Jin-San Zhang, Jianguo Du, Raul Urrutia & John Barnard. (2003) Growth inhibitory signalling by TGFβ is blocked in Ras-transformed intestinal epithelial cells at a post-receptor locus. Cellular Signalling 15:7, pages 699-708.
Crossref
Marc A. Antonyak, Conor J. McNeill, Joseph J. Wakshlag, Jason E. Boehm & Richard A. Cerione. (2003) Activation of the Ras-ERK Pathway Inhibits Retinoic Acid-induced Stimulation of Tissue Transglutaminase Expression in NIH3T3 Cells. Journal of Biological Chemistry 278:18, pages 15859-15866.
Crossref
John G Shelton, Linda S Steelman, John T Lee, Steven L Knapp, William L Blalock, Phillip W Moye, Richard A Franklin, Steven C Pohnert, Amer M Mirza, Martin McMahon & James A McCubrey. (2003) Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells. Oncogene 22:16, pages 2478-2492.
Crossref
Christophe Denoyelle, Patricia Albanese, Georges Uzan, Li Hong, Jean-Pierre Vannier, Jeannette Soria & Claudine Soria. (2003) Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells. Cellular Signalling 15:3, pages 327-338.
Crossref
Derek L Stirewalt, Soheil Meshinchi & Jerald P Radich. (2003) Molecular targets in acute myelogenous leukemia. Blood Reviews 17:1, pages 15-23.
Crossref
H Asha, Istvan Nagy, Gabor Kovacs, Daniel Stetson, Istvan Ando & Charles R Dearolf. (2003) Analysis of Ras-Induced Overproliferation in Drosophila Hemocytes. Genetics 163:1, pages 203-215.
Crossref
Jeffrey C. Chen, Shunhui Zhuang, Tony H. Nguyen, Gerry R. Boss & Renate B. Pilz. (2003) Oncogenic Ras Leads to Rho Activation by Activating the Mitogen-activated Protein Kinase Pathway and Decreasing Rho-GTPase-activating Protein Activity. Journal of Biological Chemistry 278:5, pages 2807-2818.
Crossref
Gretchen A. Murphy, Adrienne D. Cox & Channing J. Der. 2003. Handbook of Cell Signaling. Handbook of Cell Signaling
681
688
.
Galit Elad-Sfadia, Roni Haklai, Eyal Ballan, Hans-Joachim Gabius & Yoel Kloog. (2002) Galectin-1 Augments Ras Activation and Diverts Ras Signals to Raf-1 at the Expense of Phosphoinositide 3-Kinase. Journal of Biological Chemistry 277:40, pages 37169-37175.
Crossref
Kostas D. Katsanakis, Vassilis Gorgoulis, Athanasios G. Papavassiliou & Vassilis K. Zoumpourlis. (2002) The Progression in the Mouse Skin Carcinogenesis Model Correlates With ERK1/2 Signaling. Molecular Medicine 8:10, pages 624-637.
Crossref
Catherine L Olsen, Betty Gardie, Paul Yaswen & Martha R Stampfer. (2002) Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion. Oncogene 21:41, pages 6328-6339.
Crossref
Nesrin M. Hamad, Joel H. Elconin, Antoine E. Karnoub, Wenli Bai, Jeremy N. Rich, Robert T. Abraham, Channing J. Der & Christopher M. Counter. (2002) Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes & Development 16:16, pages 2045-2057.
Crossref
Benjamin Boettner & Linda Van Aelst. (2002) The RASputin effect: Figure 1.. Genes & Development 16:16, pages 2033-2038.
Crossref
Malene Hansen, Elena V Rusyn, Paul E Hughes, Mark H Ginsberg, Adrienne D Cox & Berthe M Willumsen. (2002) R-Ras C-terminal sequences are sufficient to confer R-Ras specificity toH-Ras. Oncogene 21:28, pages 4448-4461.
Crossref
Young-Ho Koh, Catalina Ruiz-Canada, Michael Gorczyca & Vivian Budnik. (2002) The Ras1–Mitogen-Activated Protein Kinase Signal Transduction Pathway Regulates Synaptic Plasticity through Fasciclin II-Mediated Cell Adhesion. The Journal of Neuroscience 22:7, pages 2496-2504.
Crossref
Ligaya L. Stice, Lora W. Forman, Chang S. Hahn & Douglas V. Faller. (2002) Desensitization of the PDGFβ Receptor by Modulation of the Cytoskeleton: The Role of p21Ras and Rho Family GTPases. Experimental Cell Research 275:1, pages 17-30.
Crossref
Gretchen A. Murphy, Suzanne M. Graham, Staeci Morita, Sarah E. Reks, Kelley Rogers-Graham, Anne Vojtek, Grant G. Kelley & Channing J. Der. (2002) Involvement of Phosphatidylinositol 3-Kinase, but Not RalGDS, in TC21/R-Ras2-mediated Transformation. Journal of Biological Chemistry 277:12, pages 9966-9975.
Crossref
James J. Fiordalisi, Stephen P. Holly, Ronald L. JohnsonIIII, Leslie V. Parise & Adrienne D. Cox. (2002) A Distinct Class of Dominant Negative Ras Mutants. Journal of Biological Chemistry 277:13, pages 10813-10823.
Crossref
Victoria Y. Gorbacheva, Daniel Lindner, Ganes C. Sen & Deborah J. Vestal. (2002) The Interferon (IFN)-induced GTPase, mGBP-2. Journal of Biological Chemistry 277:8, pages 6080-6087.
Crossref
John M. Lambert, Antoine E. Karnoub, Lee M. Graves, Sharon L. Campbell & Channing J. Der. (2002) Role of MLK3-mediated Activation of p70 S6 Kinase in Rac1 Transformation. Journal of Biological Chemistry 277:7, pages 4770-4777.
Crossref
Lawrence A Quilliam, John F Rebhun & Ariel F Castro. 2002.
391
444
.
Aron B. Jaffe & Alan Hall. 2002.
57
80
.
Ruth Halaban & Maria C. Willebrand. 2002. Melanoma. Melanoma
287
323
.
Sun Young Yoon, Moon-Jin Jeong, Jiyun Yoo, Kyung Im Lee, Byoung-Mok Kwon, Do-Seon Lim, Choong-Eun Lee, Young-Mee Park & Mi Young Han. (2002) Grb2 dominantly associates with dynamin II in human hepatocellular carcinoma HepG2 cells. Journal of Cellular Biochemistry 84:1, pages 150-155.
Crossref
Klaus Scheffzek, Petra Grünewald, Sabine Wohlgemuth, Wolfgang Kabsch, Hua Tu, Mike Wigler, Alfred Wittinghofer & Christian Herrmann. (2001) The Ras-Byr2RBD Complex. Structure 9:11, pages 1043-1050.
Crossref
Luisa Carpio, Julienne Gladu, David Goltzman & Shafaat A. Rabbani. (2001) Induction of osteoblast differentiation indexes by PTHrP in MG-63 cells involves multiple signaling pathways. American Journal of Physiology-Endocrinology and Metabolism 281:3, pages E489-E499.
Crossref
Faris Farassati, An-Dao Yang & Patrick W. K. Lee. (2001) Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1. Nature Cell Biology 3:8, pages 745-750.
Crossref
Amy S. Gladfelter, John J. Moskow, Trevin R. Zyla & Daniel J. Lew. (2001)
Isolation and Characterization of Effector-Loop Mutants of
CDC42
in Yeast
. Molecular Biology of the Cell 12:5, pages 1239-1255.
Crossref
Michael Spoerner, Christian Herrmann, Ingrid R. Vetter, Hans Robert Kalbitzer & Alfred Wittinghofer. (2001) Dynamic properties of the Ras switch I region and its importance for binding to effectors. Proceedings of the National Academy of Sciences 98:9, pages 4944-4949.
Crossref
Carol B Martin, Gwendolyn M Mahon, Mark B Klinger, Robert J Kay, Marc Symons, Channing J Der & Ian P Whitehead. (2001) The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways. Oncogene 20:16, pages 1953-1963.
Crossref
Frederick R. Appelbaum, Jacob M. Rowe, Jerald Radich & John E. Dick. (2001) Acute Myeloid Leukemia. Hematology 2001:1, pages 62-86.
Crossref
Chunhua Song, Chang-Deng Hu, Misa Masago, Ken-ichi Kariya, Yuriko Yamawaki-Kataoka, Mitsushige Shibatohge, Dongmei Wu, Takaya Satoh & Tohru Kataoka. (2001) Regulation of a Novel Human Phospholipase C, PLCε, through Membrane Targeting by Ras. Journal of Biological Chemistry 276:4, pages 2752-2757.
Crossref
Soumitro Pal, Kaustubh Datta, Roya Khosravi-Far & Debabrata Mukhopadhyay. (2001) Role of Protein Kinase Cζ in Ras-mediated Transcriptional Activation of Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression. Journal of Biological Chemistry 276:4, pages 2395-2403.
Crossref
Salvador Aznar & Juan Carlos Lacal. 2001.
193
234
.
Craig P. Webb & George F. Vande Woude. 2001. Regulators and Effectors of Small GTPases, Part G. Regulators and Effectors of Small GTPases, Part G
318
329
.
Yuji Yamazaki, Yoshito Kaziro & Hiroshi Koide. (2001) Ral Promotes Anchorage-Independent Growth of a Human Fibrosarcoma, HT10801. Biochemical and Biophysical Research Communications 280:3, pages 868-873.
Crossref
Kevin Pruitt, Richard G. Pestell & Channing J. Der. (2000) Ras Inactivation of the Retinoblastoma Pathway by Distinct Mechanisms in NIH 3T3 Fibroblast and RIE-1 Epithelial Cells. Journal of Biological Chemistry 275:52, pages 40916-40924.
Crossref
Stefan Faderl & Maher Albitar. (2000) INSIGHTS INTO THE BIOLOGIC AND MOLECULAR ABNORMALITIES IN ADULT ACUTE LYMPHOCYTIC LEUKEMIA. Hematology/Oncology Clinics of North America 14:6, pages 1267-1288.
Crossref
Alfred Wittinghofer & Herbert Waldmann. (2000) Ras—A Molecular Switch Involved in Tumor Formation. Angewandte Chemie 39:23, pages 4192-4214.
Crossref
Alfred Wittinghofer & Herbert Waldmann. (2000) Ras – ein molekularer Schalter bei der Tumorentstehung. Angewandte Chemie 112:23, pages 4360-4383.
Crossref
J A Du Villard, R Wicker, P Crespo, D Russo, S Filetti, J S Gutkind, A Sarasin & H G Suárez. (2000) Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation. Oncogene 19:42, pages 4896-4905.
Crossref
Elena V Rusyn, Evangeline R Reynolds, Haipeng Shao, Theresa M Grana, Tung O Chan, Douglas A Andres & Adrienne D Cox. (2000) Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways. Oncogene 19:41, pages 4685-4694.
Crossref
Arkadiusz Welman, Max M Burger & Jörg Hagmann. (2000) Structure and function of the C-terminal hypervariable region of K-Ras4B in plasma membrane targetting and transformation. Oncogene 19:40, pages 4582-4591.
Crossref
Christoph W. M. ReuterMichael A. MorganLothar Bergmann. (2000) Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?. Blood 96:5, pages 1655-1669.
Crossref
Christoph W. M. ReuterMichael A. MorganLothar Bergmann. (2000) Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?. Blood 96:5, pages 1655-1669.
Crossref